At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 361 enrolled
Drug / intervention
Oral iron tablets +1 moredrug
Likely dose
Oral iron tablets 325 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of the Safety and Efficacy of Intravenous Iron vs Oral Iron in Subjects Who Display Postpartum Anemia
In Brief
A Phase 3 clinical trial evaluating Oral iron tablets and VIT-45 for Anemia. Completed, enrolled 361 participants across 1 site.
Detailed Summary
This study compares the safety and efficacy of intravenous iron vs oral iron in subjects who display postpartum anemia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnemia
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartFeb 2005
Primary CompletionNov 2005
Study CompletionFeb 2006
First PostedNov 2006
TodayJul 2026
First PostedNov 6, 2006
Enrollment StartFeb 1, 2005
Primary CompletionNov 1, 2005
Study CompletionFeb 1, 2006
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 19.7 years ago
Interventions
Oral iron tabletsdrug
325 mg tablets (65 mg elemental iron) with instructions to take 1 tablet by mouth (PO) TID with 8 ounces of tap water, 1 hour before meals from Day 0 until Day 42
VIT-45drug
A maximum of 1,000 mg iron as IV VIT-45 given at weekly intervals until the the cumulative dose has been reached or a maximum of 2,500 mg has been administered